Pembro Plus Chemo: Practice-Changing for Nonsquamous mNSCLC

Share this post

Adding pembrolizumab to chemotherapy provided significant improvement in both overall and progression-free survival; the results have been hailed as practice-changing.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply